• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WILLIAM COOK EUROPE GUNTHER TULIP NAVALIGN FEMORAL VENA CAVA FILTER SET; DTK FILTER, INTRAVASCULAR, CARDIOVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WILLIAM COOK EUROPE GUNTHER TULIP NAVALIGN FEMORAL VENA CAVA FILTER SET; DTK FILTER, INTRAVASCULAR, CARDIOVASCULAR Back to Search Results
Model Number G52917
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Tachycardia (2095)
Event Date 11/19/2018
Event Type  Injury  
Manufacturer Narrative
Manufacturers ref# (b)(4).Pma/510(k) k172557.(b)(4).Investigation is still in progress.
 
Event Description
Description of event according to study: on (b)(6) 2018, subject became tachycardic during filter retrieval attempt.Heart rates (hr) were seen up to the 120-130s.Subject gradually improved while in the ir suite.Hr came down to in the low 100's.Filter retrieval attempt on (b)(6) 2018, resulted in severe pain of subject.Post-procedure pain rating was documented at a 9 on a 10 point scale.Subject responded well to pain medication while in the ir suite.On (b)(6) 2018, subject became hypoxic during filter retrieval attempt.Desaturation down to the high 80s, while also becoming tachycardic.O2 saturation improved above 92% with 6l nc.Pe was presumed and patient was anticoagulated with 5000 units of heparin.Chest x-ray (cxr) later revealed negative for pe, however cxr was suggestive of air trapping.O2 sat.Gradually improved while in the ir suite, saturating greater than 96% on 2l pm and hr lowered down to the low 100s.Patient outcome: the event resolved without sequelae and the subject was discharged on (b)(6) 2018.
 
Manufacturer Narrative
Manufacturers ref# (b)(4).Summary of investigational findings: the investigation is based on the event description only.It was reported that the patient experienced pain and became hypoxic and tachycardic during filter retrieval.Assuming the filter was successfully retrieved, as the event resolved without sequelae and the patient was discharged.No product was returned and no imaging was available and based on the limited information provided it would be inappropriate to speculate at what may or may not have caused the difficulties in retrieving the filter and the patient to experience pain and become hypoxic and tachycardic during attempted filter retrieval.It is noted that the filter was placed due to lle dvt and plans for excision of pelvic mass, but according to the instructions for use the tulip filter is intended for prevention of recurrent pe, if anticoagulant therapy has failed or is contraindicated.Physician practice guidelines and published guidance from regulatory agencies recommend that patients with indwelling filters undergo routine follow-up.The risks/benefits of filter retrieval should be considered for each patient during follow-up.Once protection from pe is no longer necessary, filter retrieval should be considered.Filter retrieval should be attempted when feasible and clinically indicated.Filter retrieval is a patient-specific, clinically complex decision; the decision to remove a filter should be based on each patient¿s individual risk/benefit profile (e.G., a patient¿s continued need for protection from pe compared to their experience with and (or) ongoing risk of experiencing filter-related complications).For all retrievable ivc filters, retrieval becomes more challenging with time, and this is commonly due to encapsulation of the filter legs or hook (in a tilted filter) by tissue ingrowth.The filter is designed to be retrieved with the günther tulip vena cava filter retrieval set.It may also be retrieved with the cloversnare® vascular retriever.Cook has not performed testing to evaluate the safety or effectiveness of filter retrieval using other retrieval systems or techniques.The published clinical literature includes descriptions of alternative techniques for filter retrieval; use of these techniques varies according to physician experience, patient anatomy, and filter position.The safety or effectiveness of these alternative retrieval techniques has not been established.Specific for ¿embedded¿ a filter that is embedded in the wall of the ivc may be difficult to retrieve.For all retrievable ivc filters, retrieval becomes more challenging with time, and this is commonly due to encapsulation of the filter legs or hook (in a tilted filter) by tissue ingrowth.There are adequate controls in place to ensure that this type of device is manufactured to specifications.It was assessed that because no non-conformances were detected, there is evidence that the dhr was fully executed.In addition, no other lot related complaints have been received from the field.It is therefore concluded that there is no evidence that nonconforming product exists in house or in field.Cook medical will continue to monitor for similar events.This report is required by the fda under 21cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event Description
No additional information regarding the patient and/or event has been received since the previous medwatch report was sent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GUNTHER TULIP NAVALIGN FEMORAL VENA CAVA FILTER SET
Type of Device
DTK FILTER, INTRAVASCULAR, CARDIOVASCULAR
Manufacturer (Section D)
WILLIAM COOK EUROPE
sandet 6
bjaeverskov 4632
DA  4632
MDR Report Key8815327
MDR Text Key151851923
Report Number3002808486-2019-01034
Device Sequence Number1
Product Code DTK
UDI-Device Identifier10827002529172
UDI-Public(01)10827002529172(17)210501(10)E3720238
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type study
Type of Report Initial,Followup
Report Date 07/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/01/2021
Device Model NumberG52917
Device Catalogue NumberIGTCFS-65-1-FEM-TULIP
Device Lot NumberE3720238
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/28/2019
Initial Date FDA Received07/23/2019
Supplement Dates Manufacturer Received07/03/2020
Supplement Dates FDA Received07/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Age27 YR
-
-